Abstract
Background
Xenon computed tomography (Xe-CT) provides quantitative information on tissue blood flow (TBF). In the present study, Xe-CT was performed in patients with esophagogastric varices (EGV) before and after endoscopic injection sclerotherapy (EIS) to evaluate hepatic blood flow (HBF), hepatic arterial TBF (HATBF) and portal venous TBF (PVTBF).
Methods
Subjects comprised of 88 patients with EGV (49 men, 39 women, average age 65.8 ± 11.5 years, median age 68 years, 30–86 years) and liver cirrhosis related to either hepatitis C virus (C) (n = 33), hepatitis B virus (B) (n = 3), alcohol (AL) (n = 22), AL + C (n = 7), AL + B (n = 1), B + C + AL (n = 1), nonalcoholic steatohepatitis (NASH) (n = 4), autoimmune hepatitis (AIH) (n = 5), primary biliary cirrhosis (PBC) (n = 2), or cryptogenic (n = 10) were enrolled. All patients, who were enrolled in this study, were performed EIS for prophylaxis. Xe-CT and measurement of the retention rate of indocyanine green 15 min after administration (ICG R15) were performed before and after EIS. Total hepatic TBF (THTBF) and PVTBF/HATBF ratio (P/A) were also calculated.
Results
PVTBF, HATBF, THTBF, P/A and ICG R15 before EIS were 28.3 ± 8.91, 22.5 ± 14.4 and 50.8 ± 17.6 ml/100 ml/min, 1.62 ± 0.71 and 28.8 ± 12.7 %, respectively and those after EIS were 31.9 ± 10.0, 19.3 ± 11.6, and 51.2 ± 17.0 ml/100 ml/min, 1.92 ± 0.84 and 23.6 ± 11.3 %, respectively. PVTBF and P/A after EIS were significantly higher than those before EIS (p = 0.00444, p = 0.0179, respectively), and HATBF and ICG R15 after EIS were significantly lower than those before EIS (p = 0.00129, p < 0.001, respectively).
Conclusions
Xenon computed tomography showed that PVTBF increased after EIS for EGV and HATBF decreased in response to an increase in PVTBF.
Similar content being viewed by others
Abbreviations
- Xe-CT:
-
Xenon computed tomography
- TBF:
-
Tissue blood flow
- EGV:
-
Esophagogastric varices
- HBF:
-
Hepatic blood flow
- HATBF:
-
Hepatic arterial tissue blood flow
- PVTBF:
-
Portal venous tissue blood flow
- THTBF:
-
Total hepatic tissue blood flow
- P/A:
-
Portal venous tissue blood flow/hepatic arterial tissue blood flow ratio
- CLD:
-
Chronic liver disease
- LC:
-
Liver cirrhosis
- B:
-
Hepatitis B virus
- C:
-
Hepatitis C virus
- AL:
-
Alcohol
- NASH:
-
Nonalcoholic steatohepatitis
- AIH:
-
Autoimmune hepatitis
- PBC:
-
Primary biliary cirrhosis
- EIS:
-
Endoscopic injection sclerotherapy
- ICG R15:
-
The retention rate of indocyanine green 15 min after administration
- US:
-
Ultrasonography
- CT:
-
Computed tomography
- MRI:
-
Magnetic resonance imaging
- ROI:
-
Region of interest
References
Gur D, Good WF, Wolfson SK Jr, Yonas H, Shabason L. In vivo mapping of local cerebral blood flow by xenon-enhanced computed tomography. Science. 1982;215:1267–8.
Leopold D, Zinreich SJ, Simon BA, Cullen MM, Marcucci C. Xenon-enhanced computed tomography quantifies normal maxillary sinus ventilation. Otolaryngol Head Neck Surg. 2000;122:422–4.
Sase S, Suzuki M, Ikeda H, Takahashi H, Okuse N, Maeyama S, et al. Quantitative multilevel mapping of hepatic blood flow by xenon computed tomography using the aorta. J Comput Assist Tomogr. 2003;27:647–51.
Ikeda H, Suzuki M, Kobayashi M, Takahashi H, Matsumoto N, Maeyama S, et al. Xenon computed tomography shows hemodynamic change during the progression of chronic hepatitis C. Hepatol Res. 2007;37:104–12.
Takahashi H, Suzuki M, Ikeda H, Kobayashi M, Sase S, Yotsuyanagi H, et al. Evaluation of quantitative portal venous, hepatic arterial and total hepatic tissue blood flow using Xenon CT in alcoholic liver cirrhosis-comparison with liver cirrhosis C. Alcohol Clin Exp Res. 2007;31:S43–8.
Kobayashi M, Suzuki M, Ikeda H, Takahashi H, Matsumoto N, Maeyama S, et al. Assessment of hepatic steatosis and hepatic tissue blood flow by xenon computed tomography in nonalcoholic steatohepatitis. Hepatol Res. 2009;39(1):31–9.
Takahashi H, Suzuki M, Ikeda H, Kobayashi M, Sase S, Yotsuyanagi H, et al. Evaluation of quantitative portal venous, hepatic arterial, and total hepatic tissue blood flow using xenon CT in alcoholic liver cirrhosis-comparison with liver cirrhosis related to Hepatitis C virus and nonalcoholic steatohepatitis. Alcohol Clin Exp Res. 2010;34:S7–13.
Sase S, Monden M, Oka H, Dono K, Fukuta T, Shibata I. Hepatic blood flow measurements with arterial and portal blood flow mapping in the human liver by means of xenon CT. J Comput Assist Tomogr. 2002;26:243–9.
Sase S, Takahashi H, Ikeda H, Kobayashi M, Matsumoto N, Suzuki M, et al. Determination of time-course change rate for arterial xenon using the time course of tissue xenon concentration in xenon-enhanced computed tomography. Med Phys. 2008;35:2331–8.
Shigefuku R, Takahashi H, Kobayashi M, Ikeda H, Matsunaga K, Okuse C, et al. Pathophysiological analysis of nonalcoholic fatty liver disease by evaluation of fatty liver changes and blood flow using xenon computed tomography: can early-stage nonalcoholic steatohepatitis be distinguished from simple steatosis? J Gastroenterol. 2012;47:1238–47.
Annet L, Materne R, Danse E, Jamart J, Horsmans Y, Van Beers BE. Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension. Radiology. 2003;229:409–14.
Bernatik T, Strobel D, Hahn EG, Becker D. Doppler measurements: a surrogate marker of liver fibrosis? Eur J Gastroenterol Hepatol. 2002;14:383–7.
Fujita Y, Watanabe M, Sasao K, Wakui N, Shinohara M, Ishii K, et al. Investigation of liver parenchymal flow using contrast-enhanced ultrasound in patients with alcoholic liver disease. Alcohol Clin Exp Res. 2004;28:S169–73.
Hirata M, Kurose K, Minami H, Kumagi T, Akbar SM, Michitaka K, et al. Clinical characteristics of portal hemodynamics in alcoholic liver cirrhosis. Alcohol Clin Exp Res. 2004;28:S148–52.
Chiandussi L, Greco F, Sardi G, Vaccarino A, Ferraris CM, Curti B. Estimation of hepatic arterial and portal venous blood flow by direct catheterization of the vena porta through the umbilical cord in humans. Preliminary results. Acta Hepatosplenol. 1968;15:166–71.
Materne R, Smith AM, Peeters F, Dehoux JP, Keyeux A, Horsmans Y, et al. Assessment of hepatic perfusion parameters with dynamic MRI. Magn Reson Med. 2002;47:135–42.
Van Beers BE, Leconte I, Materne R, Smith AM, Jamart J, Horsmans Y. Hepatic perfusion parameters in chronic liver disease: dynamic CT measurements correlated with disease severity. Am J Roentgenol. 2001;176(3):667–73.
Tajiri T, Yoshida H, Obara K, Onji M, Kage M, Kitano S, et al. General rules for recording endoscopic findings of esophagogastric varices (2nd edition). Dig Endosc. 2010;22(1):1–9.
Allen EM. Good clinical practice in Euroupe: investigator’s handbook. Romford: Essex; 1991. p. 73–6.
Visscher MB, Johnson JA. The Fick’s Principle: analysis of potential errors and its conventional applications. J Appl Physiol. 1953;5:535.
Bradley SE, Ingelfinger FJ, Bradley GP. Hepatic circulation in cirrhosis of the liver. Circulation. 1952;5:419–29.
Newby DE, Hayes PC. Hyperdynamic circulation in liver cirrhosis: not peripheral vasodilatation but ‘splanchnic steal’. QJM. 2002;95(12):827–30.
Richter S, Mucke I, Menger MD, Vollmar B. Impact of intrinsic blood flow regulation in cirrhosis: maintenance of hepatic arterial buffer response. Am J Physiol Gastrointest Liver Physiol. 2000;279:G454–62.
Gulberg V, Haag K, Rossle M, Gerbes AL. Hepatic arterial buffer response in patients with advanced cirrhosis. Hepatology. 2002;35:630–4.
Witte CL, Witte MH, Krone CL. Contrasting hemodynamic patterns of portal hypertension. Ann Surg. 1972;176:68–79.
Lautt WW, Greenway CV. Conceptual review of the hepatic vascular bed. Hepatology. 1987;7(5):952–63.
Tygstrup N, Winkler K, Mellemgaard K, Andreassen M. Determination of the hepatic arterial blood flow and oxygen supply in man by clamping the hepatic artery during surgery. J Clin Invest. 1962;41:447–54.
Sato N, Eguchi H, Inoue A, Matsumura T, Kawano S, Kamada T. Hepatic microcirculation in Zucker fatty rats. Adv Exp Med Biol. 1986;200:477–83.
Hayashi N, Kasahara A, Kurosawa K, Sasaki Y, Fusamoto H, Sato N, et al. Oxygen supply to the liver in patients with alcoholic liver disease assessed by organ-reflectance spectrophotometry. Gastroenterology. 1985;88(4):881–6.
Hayashi N, Kasahara A, Kurosawa K, Yoshihara H, Sasaki Y, Fusamoto H, et al. Hepatic hemodynamics in alcoholic liver injuries assessed by reflectance spectrophotometry. Alcohol. 1985;2(3):453–6.
Kasahara A, Hayashi N, Kurosawa K, Sasaki Y, Sato N, Kamada T. Hepatic hemodynamics and oxygen consumption in alcoholic fatty liver assessed by organ-reflectance spectrophotometry and the hydrogen clearance method. Hepatology. 1986;6(1):87–91.
Leung TM, Tipoe GL, Liong EC, Lau TY, Fung ML, Nanji AA. Endothelial nitric oxide synthase is a critical factor in experimental liver fibrosis. Int J Exp Pathol. 2008;89(4):241–50.
Hernández-Guerra M, García-Pagán JC, Turnes J, Bellot P, Deulofeu R, Abraldes JG, et al. Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension. Hepatology. 2006;43(3):485–91.
Iwata K, Shijo H, Kamimura S, Uehara Y, Kitamura Y, Iida T, et al. Effects of esophageal varices obliteration by endoscopic variceal sclerotherapy on asialoscintigraphy and liver function test. Hepatol Res. 2002;22(1):45–51.
Acknowledgments
The authors wish to thank the technical assistants at the Imaging Center of St. Marianna University School of Medicine Hospital for their assistance.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Takahashi, H., Suzuki, M., Shigefuku, R. et al. Xenon computed tomography can evaluate the improvement of hepatic hemodynamics before and after endoscopic injection sclerotherapy. J Gastroenterol 48, 1353–1361 (2013). https://doi.org/10.1007/s00535-013-0756-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00535-013-0756-7